Biocon
Jayesree Nagarajan, Ph.D., is an accomplished professional in the field of quality control and analytical chemistry, currently serving as Deputy Manager of Quality Control Analytical at Biocon since May 2021. Previously, Jayesree held roles as Assistant Manager of Quality Control Analytical and Principal Scientist R&D at Biocon. Experience includes working as Executive API Analytical at Oncogen Pharma Malaysia from August 2019 to April 2021, and as Research Associate at both Monash University from January 2015 to June 2019 and Universiti Selangor from March 2013 to February 2014. Academic credentials include a Doctor of Philosophy in Chemical Engineering from Monash University Malaysia, a Master's Degree in Biotechnology from Universiti Industri Selangor, and a Bachelor's of Science (Hons) in Biotechnology from Universiti Tunku Abdul Rahman.
This person is not in any teams
This person is not in any offices
Biocon
22 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.